XXXX : diagnosis, treatment, and prognosis.

@entity1 @entity1032 @entity1467 @entity6750 @entity44 @entity1374
@entity6750 is a common but preventable cause of @entity1032 . The incidence of @entity6750 in the newborn population is about 1:3500 to 1:4000. @entity1 with @entity1467 are at a special risk. Fort et al. reported an incidence of persistent primary @entity6750 in @entity1 with @entity1467 of 1:141 or 28 times higher than the general newborn population. Premature @entity1 have varying degrees of @entity44 of @entity1374 and are at a special risk for a variety of @entity1374 . These @entity1 need adequate understanding and interpretation of their laboratory values before institution of replacement hormonal therapy. Screening programs are available in 48 states and have led to prompt diagnosis and recognition of most cases that would otherwise be missed. Prevention of @entity1032 depends on early and adequate treatment. This requires close cooperation between the program and the physicians involved in the care of the @entity1 . Many state screening programs maintain a list of experts who are available for consultation, if necessary.
